Clinical trial
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
NCT03451734 is registered in ClinicalTrials.gov with Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
- Lead sponsor
- Central South University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 23, 2018
- Completion date
- June 30, 2021
- Enrollment
- 2,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.